부산대학교 도서관

Mortality rates in COVID-19 ARDS were higher than prepandemic ARDS (39.4% vs 28.5%; I p i < 0.001), and the presence of pneumothorax/pneumomediastinum increased the 30-day mortality in COVID-19 ARDS patients (49.5% vs 36.2%; I p i < 0.001). Keywords: barotrauma; COVID-19 acute respiratory distress syndrome; mortality; pneumomediastinum EN barotrauma COVID-19 acute respiratory distress syndrome mortality pneumomediastinum 145 148 4 12/19/22 20230101 NES 230101 Severe acute respiratory distress syndrome (ARDS) related to COVID-19 has been described since the end of 2019 when COVID-19 pandemic started in Wuhan, China. In a recent systematic review and meta-analysis, Shrestha et al ([3]) reported barotrauma in 4.2% (2.4-7.3%) among hospitalized COVID-19 patients, 15.6% (11-21%) among critically ill COVID-19 patients, and 18.4% (13-25.3%) in COVID-19 patients receiving invasive mechanical ventilation in 15 observational studies (2,286 patients). [Extracted from the article]